Correlation Between Entera Bio and TRACON Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Entera Bio and TRACON Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entera Bio and TRACON Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entera Bio and TRACON Pharmaceuticals, you can compare the effects of market volatilities on Entera Bio and TRACON Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entera Bio with a short position of TRACON Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entera Bio and TRACON Pharmaceuticals.
Diversification Opportunities for Entera Bio and TRACON Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Entera and TRACON is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Entera Bio and TRACON Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TRACON Pharmaceuticals and Entera Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entera Bio are associated (or correlated) with TRACON Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TRACON Pharmaceuticals has no effect on the direction of Entera Bio i.e., Entera Bio and TRACON Pharmaceuticals go up and down completely randomly.
Pair Corralation between Entera Bio and TRACON Pharmaceuticals
Given the investment horizon of 90 days Entera Bio is expected to generate 0.45 times more return on investment than TRACON Pharmaceuticals. However, Entera Bio is 2.2 times less risky than TRACON Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. TRACON Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 74.00 in Entera Bio on November 3, 2024 and sell it today you would earn a total of 145.00 from holding Entera Bio or generate 195.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 40.32% |
| Values | Daily Returns |
Entera Bio vs. TRACON Pharmaceuticals
Performance |
| Timeline |
| Entera Bio |
| TRACON Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Entera Bio and TRACON Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Entera Bio and TRACON Pharmaceuticals
The main advantage of trading using opposite Entera Bio and TRACON Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entera Bio position performs unexpectedly, TRACON Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will offset losses from the drop in TRACON Pharmaceuticals' long position.| Entera Bio vs. NLS Pharmaceutics AG | Entera Bio vs. Alterity Therapeutics | Entera Bio vs. Immutep Ltd ADR |
| TRACON Pharmaceuticals vs. Rezolute | TRACON Pharmaceuticals vs. XOMA Corp | TRACON Pharmaceuticals vs. Vincerx Pharma | TRACON Pharmaceuticals vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |